Free
Correspondence  |   July 2003
It's the Colloid, Not the Esophageal Doppler Monitor
Author Affiliations & Notes
  • Tong J. Gan, M.D.
    *
  • *Duke University Medical Center, Durham, North Carolina.
Article Information
Correspondence
Correspondence   |   July 2003
It's the Colloid, Not the Esophageal Doppler Monitor
Anesthesiology 7 2003, Vol.99, 239. doi:
Anesthesiology 7 2003, Vol.99, 239. doi:
In Reply:—
Thank you for allowing us the opportunity to respond to the letter by Horowitz and Kumar. In our study, 1 we investigated whether goal-directed intraoperative plasma volume expansion guided by the esophageal Doppler monitor would shorten the length of hospital stay and improve postoperative outcomes. The control and protocol groups consisted of patients undergoing similar procedures. The general anesthetic for both groups was standardized. We did not regiment the type of fluid to be administered in the control group, because we wanted this group to receive, as closely as possible, a routine standard of care. The protocol group received 6% hetastarch in saline to a maximum of 20 ml/kg, based on a fluid challenge algorithm. Patients in the protocol group received, on average, 500 ml more colloid than the control group. Hence, we could not completely rule out that additional colloid may have contributed to the findings of our study. This was stated in the discussion of the original manuscript. Goal-directed fluid administration is a strategy. Using the fluid challenge algorithm with esophageal Doppler monitoring minimizes the risk of over-resuscitation, because stroke volume is reassessed before each additional fluid bolus.
A number of confounding factors in this study must be addressed in future studies. First is the timing of fluid administration. A significantly greater volume of intravenous fluid was administered toward the beginning of the surgical procedure in the protocol group than in the control group. It may be that the earlier administration of fluid resulted in better perfusion of the gastrointestinal tract and, hence, earlier resumption of gastrointestinal motility and return to normal diet.
The type of fluid administered may also be important in postoperative patient outcome. In a recent study, 2 we found an improvement in the quality of recovery in patients receiving a combination of colloid (6% hetastarch) and crystalloid (lactated Ringer's) versus  crystalloid alone. Specifically, the colloid/crystalloid patients had a lower incidence of postoperative nausea and vomiting, severe pain, and peripheral edema. Further investigations are therefore needed to study the contribution of these factors.
References
Gan TJ, Soppitt A, Maroof M, El-Moalem H, Robertson KM, Moretti E, Dwane P, Glass PSA: Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. A nesthesiology 2002; 97: 820–6Gan, TJ Soppitt, A Maroof, M El-Moalem, H Robertson, KM Moretti, E Dwane, P Glass, PSA
Moretti E, Robertson KM, El-Moalem H, Gan TJ: Intraoperative colloid administration reduces postoperative nausea and vomiting and improves postoperative outcomes compared to crystalloid administration. Anesth Analg 2003; 96: 611–7Moretti, E Robertson, KM El-Moalem, H Gan, TJ